2018 FORUM THEME

U.S.-China Dialogue

in an Era of Transformation

8:00

9:00 

9:15 

10:00 

11:00 

12:00 

13:00 

14:00 

14:15 

15:15 

15:30 

16:50 

17:30 

 

 

Forum Check-in

 

Forum starts, Opening remarks

 

Keynote Speech

 

Economics Panel

 

FinTech Panel

 

-----Lunch-----

 

Technology Panel

 

-----Break-----

 

Dentsply Sirona Healthcare Panel

 

-----Break-----

 

Private Equity Panel

 

Closing Remarks

 

Cocktail starts at Cloister Club

 

 

 

 

FORUM AGENDA

*This schedule is subject to change

Economics Panel

Join the Becker Friedman Institute for Economics (BFI) in welcoming Charles Evans, the President and CEO of the Federal Reserve Bank of Chicago, and Lars Peter Hansen, the David Rockefeller Distinguished Service Professor at the University of Chicago, for a special panel discussion during the Graduate China Forum. Evans and Hansen will evaluate the post-financial crisis regulatory framework in the United States, broader global economic conditions, and their interactions with U.S. monetary policy.

Fintech Panel

-   What is special about blockchains and cryptocurrencies? What are the pain points in the current blockchain platforms and applications? Beyond cryptocurrencies, how traditional firms are utilizing the technology? How has regulatory measures altered industry landscape?  

 - How should we think about security protection for application data, logic and operating environment? How do we capture and utilize big data/alternative data/unstructured data (textual/voice/visual)? What role can financial professionals play in the age of big data and AI?

 - How is FinTech transforming financial advising and wealth management? What does it take for robo-advising to succeed? Are crowdfunding and ICOs challenging the role of traditional capital? How are trading, clearing, and risk management affected?

 - In pursuit of their global ambition, Chinese technology heavyweights such as BAT are penetrating new product markets overseas to diversify revenue streams and reduce their home-ground reliance. What can U.S. tech companies learn from China and vice versa? Do you see technology firms and traditional financial institutions respond differently to the FinTech development in the two countries? 

Technology Panel

- In the technology investment space, tech giants such as Tencent and Alibaba, have played an increasingly active role in tech companies, not only in China but also around the world. What drives Chinese tech giants to participate actively in tech investing spaces? How does this trend relate to their increasing participation in the global market? Will other leading Chinese tech players follow their lead and expand overseas as domestic markets in China continue to mature?

- Investments in the U.S. in AI development are 1.5 times higher than in China and the talent pool is twice as large. What industries are most affected by AI in China? What are the major factors causing China to lag behind the U.S.? What are the most popular growth areas and strengths of AI development in both China and the U.S.?

- Primary uses of artificial intelligence include image recognition, object identification, detection, and classification, as well as automated geophysical feature detection. The advancement of AI development has outpaced traditional perception. What is status of AI development and application in China? How will this impact our personal and professional life?

- The future of AI will have a strong impact on the professional service industry. Will automated networked AI applications and robotic devices substantially take over blue collar and white collar jobs? Will the advances in AI lead to economic and political impacts such as depressed employment, income inequality, and social order breakdown?

Dentsply Sirona Healthcare Panel

- What is the future of healthcare reform, and what are the greatest challenges facing Chinese regulators?

- What are the latest opportunities in the healthcare industry and how will the Trump Administration change the industrial landscape?

- What are the most significant factors that a provincial government should consider when attracting companies in pharmaceuticals, consumer health, vaccines, medical devices and other related industries?

- How can healthcare industry leaders in the U.S. and China better collaborate under the opportunistic market environment supported by the Chinese government?

Private Equity Panel

- Fund raising in China has continued to grow in 2017, due to strong capital supply from insurers, money managers as well as government-led funds. As a result, PE investments in China have hit a record level in 2017. Is China at the risk of overheating? How has the strong fund raising affecting the competitiveness of the industry overall? Could too much money hurt the PE industry in China?

- Cross-border private equity investments have been made between the U.S. and China, particularly in healthcare, sports and entertainment, and fintech sectors. What is driving this trend? How are PE investors and other market players reacting to it?

- In addition to Sino-U.S. deals, increasingly sophisticated Chinese PE investors are looking into investment opportunities in the rest of the world. How will regulatory and political tailwind (and headwind) impact the trend? In particular, how has Chinese private equity investors involved in the Belt and Road Initiative?

- Exiting from investments have been challenging in the past year for PE investments since there is a long queue for IPO on Stock Exchanges in mainland China. It was expected that exit through A share and overseas listings may accelerate. What would it look like in 2018?

- Chinese companies are transitioning from being followers to innovators.  In 2017, China accounts for 39% of total number of Unicorns globally, only after US’s 42%. What is PE investors’ role in this paradigm shift? How could Unicorns (private companies with $1BN+ valuation) in China and the U.S. learn from each other?